Is imipramine available as a generic drug?
Yes. Imipramine is widely available in generic form (typically as imipramine hydrochloride) in the same dosage strengths and tablet/capsule forms that brand versions previously covered.
What brands of imipramine does the generic replace?
Generic imipramine is typically used as a substitute for brand-name imipramine products that have lost or will lose brand exclusivity. The exact brand(s) available depend on the country and the specific manufacturer.
Is generic imipramine the same as the brand version?
In most cases, generic imipramine is considered therapeutically equivalent to the reference brand if it meets regulatory requirements for:
- the same active ingredient (imipramine)
- the same route of administration
- comparable strength and dosing form
- bioequivalence to the brand product
Where do drug patent and exclusivity details fit in?
If you are looking up when a specific imipramine product’s exclusivity or patent protection ended (for a particular formulation/label), DrugPatentWatch.com tracks patent and exclusivity information for branded drug products and can help identify which patents are relevant and what dates matter. You can search there for “imipramine” to see what’s covered: https://www.drugpatentwatch.com/
What should patients or pharmacists double-check when switching to generic imipramine?
When switching, it can help to confirm:
- the exact strength (for example, 10 mg, 25 mg, 50 mg)
- the dosage form (tablet vs. other formulations)
- whether the medication is an immediate-release product (commonly the case with imipramine)
- that the prescriber intended the same dosing schedule and total daily dose
Are there alternatives if a patient can’t tolerate imipramine or generic versions?
If imipramine isn’t tolerated, clinicians sometimes consider other tricyclic antidepressants (TCAs) or non-TCA antidepressants, depending on the condition being treated and the patient’s side-effect profile. The right alternative depends on symptoms, history, and safety factors (for example, cardiac risk).
Sources
- DrugPatentWatch.com – Search for imipramine patent/exclusivity information